http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-602075-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_848098e0b79b61b483892be71b2cb27b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51dcb15bac19f1ed15137e2385e165d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00e5b784e05f763e2bd324dc965ed858
publicationDate 2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-602075-A
titleOfInvention Abuse-resistant formulations
abstract 602075 Provided is a sustained-release oral dosage form suitable for twice-a-day administration comprising a matrix which contains a viscosity modifier in an amount from about 1 to about 10 percent by weight of the dosage form selected from sodium alginate, hydroxypropylmethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone, crosslinked polyacrylic acid, gelatin, pectins, gums, polyethylene oxides, Konjac flour, carrageenan, xanthan gum, and mixtures thereof and comprises coated granules containing hydrocodone, wherein the core of the coated granules contains less than 5% fat/wax. The dosage form can have a release profile such that 6 hours following administration, less than about 80 percent of the hydrocodone is released. In addition, the dosage form may have alcohol and/or crush resistance
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10966932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9872837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572779-B2
priorityDate 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID78372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID78372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284569

Total number of triples: 45.